Catyalyst (CPRX) Updates on Pipeline; Sees Filling NDA for Firdapse After Q115
Tweet Send to a Friend
Catyalyst Pharmaceutical Partners, Inc. (NASDAQ: CPRX) provided an update on its research and development pipeline.
Portfolio update
Firdapse
This article: 1129 words
-->
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Portfolio update
Firdapse
This article: 1129 words
-->
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
